About
Drug Delivery
Areas of Focus
Categories
VaccineGene Therapy, RNA & Peptide TherapyDrug Delivery & FormulationNorway
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
209
By Phase
PHASE2: 2PHASE1: 4
By Status
COMPLETED: 4TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04099888Lead Sponsor
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
PHASE2Terminated
41 participants
Started: May 23, 2019 · Completed: May 6, 2022
NCT02947854Lead Sponsor
Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant
PHASE1Completed
96 participants
Started: Sep 30, 2016 · Completed: Mar 26, 2018
NCT01900158Lead Sponsor
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
PHASE1Completed
24 participants
Started: May 31, 2013 · Completed: Feb 28, 2019
NCT01606566Lead Sponsor
A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
PHASE2Terminated
26 participants
Started: Apr 30, 2012 · Completed: Jan 31, 2016
NCT01872923Lead Sponsor
Dose Escalating Study for Amphinex-based PCI of Bleomycin.
PHASE1Completed
3 participants
Started: Jan 31, 2012 · Completed: Feb 28, 2013
Funding History (1)
D
Mar 16, 2021
Locations (1)
Headquarters
Oslo, Norway
Map
Loading map...